Ginkgo Bioworks Holdings, Inc. (DNA)
7.805
+0.08
(+1.10%)
USD |
NYSE |
Apr 15, 16:00
7.82
+0.02
(+0.19%)
After-Hours: 20:00
Ginkgo Bioworks Holdings EPS Diluted (Quarterly) : -1.456 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.75M |
| Revenue (Quarterly) | 33.40M |
| Total Expenses (Quarterly) | 114.15M |
| Enterprise Value | 488.29M |
| Gross Profit Margin (Quarterly) | 51.30% |
| Profit Margin (Quarterly) | -241.8% |
| Earnings Yield | -72.82% |
| Normalized Earnings Yield | -73.04 |